Immune Thrombocytopenia: The Never-Ending Enigma

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Pediatric Hematology-Oncology Research Seminar Series session will take place on Thursday, January 27, 2022 at 8:00 A.M. Live attendance for this session will only be available through Zoom.

Activity Information

Needs Statement

Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and research nurses in pediatric hematology-oncology need to be regularly updated on the latest data from clinical trials in pediatric patients with hematological-oncological disorders, on the advances in the development of targeted therapies, on the developments in ethical/legal issues related to end of life care, and on the new practice standards for follow-up care for long-term survivors. The series aims to increase knowledge and skills of the learners in these topic areas in order to enhance the quality of care, increase patient safety, and improve patient outcomes.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

  • Demonstrate a greater understanding about mechanisms of platelet count maintenance at steady-state and in patients with immune thrombocytopenic purpura (ITP).
  • Discuss the contributions of sialic acid to thrombopoiesis and platelet clearance.
  • Recognize how disruptions of carbohydrate synthesis contribute to thrombopoiesis and cause immune responses in the bone marrow niche that may present a new for of ITP.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses

Specialties

  • Nuclear Medicine
  • Pathology
  • Pediatrics

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Director

  1. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Karin Hoffmeister, M.D. Placeholder Image

    Karin Hoffmeister, M.D.

    Professor of Biochemistry and Medicine
    Medical College of Wisconsin

    Disclosure:
    • Consultancy: Pfizer; Platelet Biogenesis

Activity Director

  1. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Takeda Pharmaceuticals

Planning Committee Members

  1. Jonathan Flanagan, Ph.D.

    Jonathan Flanagan, Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Terzah Horton, M.D., Ph.D.

    Terzah Horton, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Takeda Pharmaceuticals
  3. YoungNa Lee-Kim, M.D. Placeholder Image

    YoungNa Lee-Kim, M.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Donald Williams Parsons, M.D., Ph.D.

    Donald Williams Parsons, M.D., Ph.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Karin Hoffmeister, M.D.

Professor of Biochemistry and Medicine Medical College of Wisconsin

Health Topics

You May Also Be Interested In

Upcoming
Citywide Infectious Diseases Conference
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Pediatric Hematology-Oncology Research Seminar Series
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Pediatric Hematology-Oncology Research Seminar Series
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available